pubrio
BioNTech SE

BioNTech SE

Germany · Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

BioNTech is committed to improving the health of people worldwide through fundamental research and development of immunotherapies and mRNA vaccines. The company combines scientific rigor, innovation, and passion to translate science into survival. BioNTech's therapeutic areas include oncology, infectious diseases, and other serious diseases. The company's approach involves leveraging the immune system's mechanisms to develop therapies and vaccines that improve standards of care or establish new ones.

Company Insights
Company Overview

2008

Founded

Biotechnology

Industry

Germany

Location

285,446,349

Ranking

5,000 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding BioNTech SE

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​